Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Daina

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Pediatric Nephrology (Berlin, Germany)|November 26, 2015
Liver transplantation for aHUS: still needed in the eculizumab era?Rosanna Coppo, Roberto Bonaudo, R Licia Peruzzi, et al.
Kidney International Reports|January 15, 2025
Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative GlomerulonephritisAndrew S Bomback, Erica Daina, Giuseppe Remuzzi, et al.
Blood|July 20, 2002
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndromeGiuseppe Remuzzi, Miriam Galbusera, Marina Noris, et al.
Kidney International Reports|November 13, 2024
Exuberant Endothelial C5b-9 Formation in Recurrent and <i>De Novo</i> Posttransplant Thrombotic MicroangiopathySistiana Aiello, Sara Gastoldi, Elena Bresin, et al.
Blood|April 14, 2005
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case reportMiriam Galbusera, Elena Bresin, Marina Noris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2019
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical TrialPiero Ruggenenti, Erica Daina, Alessia Gennarini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 13, 2025
Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GlomerulonephritisMalak Ghaddar, Fernando Caravaca-Fontán, Manuel Praga, et al.
Journal of the American Society of Nephrology : JASN|October 15, 2017
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GNParaskevas Iatropoulos, Erica Daina, Manuela Curreri, et al.
Molecular Immunology|February 20, 2016
Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcomeParaskevas Iatropoulos, Marina Noris, Caterina Mele, et al.
Scientific Reports|February 20, 2019
Urinary proteome signature of Renal Cysts and Diabetes syndrome in childrenPierbruno Ricci, Pedro Magalhães, Magdalena Krochmal, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Pediatric Nephrology (Berlin, Germany)|November 26, 2015
Liver transplantation for aHUS: still needed in the eculizumab era?Rosanna Coppo, Roberto Bonaudo, R Licia Peruzzi, et al.
Kidney International Reports|January 15, 2025
Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative GlomerulonephritisAndrew S Bomback, Erica Daina, Giuseppe Remuzzi, et al.
Blood|July 20, 2002
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndromeGiuseppe Remuzzi, Miriam Galbusera, Marina Noris, et al.
Kidney International Reports|November 13, 2024
Exuberant Endothelial C5b-9 Formation in Recurrent and <i>De Novo</i> Posttransplant Thrombotic MicroangiopathySistiana Aiello, Sara Gastoldi, Elena Bresin, et al.
Blood|April 14, 2005
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case reportMiriam Galbusera, Elena Bresin, Marina Noris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2019
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical TrialPiero Ruggenenti, Erica Daina, Alessia Gennarini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 13, 2025
Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GlomerulonephritisMalak Ghaddar, Fernando Caravaca-Fontán, Manuel Praga, et al.
Journal of the American Society of Nephrology : JASN|October 15, 2017
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GNParaskevas Iatropoulos, Erica Daina, Manuela Curreri, et al.
Molecular Immunology|February 20, 2016
Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcomeParaskevas Iatropoulos, Marina Noris, Caterina Mele, et al.
Scientific Reports|February 20, 2019
Urinary proteome signature of Renal Cysts and Diabetes syndrome in childrenPierbruno Ricci, Pedro Magalhães, Magdalena Krochmal, et al.
Pageof 4